ESC Premium Access

Extended duration betrixaban in acutely ill medical patients is associated with reduction in fatal or irreversible ischemic or bleeding events compared with standard dose enoxaparin: an APEX substudy

Congress Session

About the speaker

Doctor Gerald Chi

Harvard Medical School, Boston (United States of America)
0 follower

71 more presentations in this session

Proprotein convertase subtilisin/kexin type 9 (PCSK9), platelet activation and risk of cardiovascular events in atrial fibrillation

Speaker: Professor P. Pignatelli Spinazzola (Rome, IT)

Thumbnail

Factor V Leiden related risk of thromboembolic and bleeding complications in patients with established coronary heart disease.

Speaker: Doctor B. Mahmoodi (Nieuwegein, NL)

Thumbnail

Factor V Leiden and prothrombin G20210A mutations in patients with premature myocardial infarction.

Speaker: Professor L. Rallidis (Athens, GR)

Thumbnail

Angiographic and hemodynamic modifications of Myocardial Bridge during supine bicycle exercise

Speaker: Doctor J. Adjedj (Saint Laurent du Var, FR)

Thumbnail

Intracoronary electrocardiographic parameters predict mortality rates at mid-term follow-up (up to 60 months) after stenting coronary bifurcation lesions

Speaker: Associate Professor K. Karamfiloff (Sofia, BG)

Thumbnail

Access the full session

Poster session 2 - Coronary artery disease: from bench to bedside

Speakers: Doctor G. Chi, Professor P. Pignatelli Spinazzola, Doctor B. Mahmoodi, Professor L. Rallidis, Doctor J. Adjedj...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk